Gene expression signature-based screening identifies new broadly effective influenza A antivirals

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Josset, Laurence ^a,b   Textoris, Julien ^c,d,e   Loriod, Béatrice ^c   Ferraris, Olivier ^a   Moules, Vincent ^a   Lina, Bruno ^a,b   N'Guyen, Catherine ^c   Diaz, Jean Jacques ^d   Rosa Calatrava, Manuel ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOBENZENESULFONAMIDE; ANTIVIRUS AGENT; BENZENESULFONAMIDE DERIVATIVE; BRINZOLAMIDE; DIMETHYL SULFOXIDE; FOLINATE CALCIUM; HARMOL; MERBROMIN; MIDODRINE; RIBAVIRIN; RILMENIDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RESEARCH; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; INFLUENZA VIRUS A H7N1; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78049302135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013169     Document Type: Article

References (73)

1. Kash JC (2009) Applications of high-throughput genomics to antiviral research: evasion of antiviral responses and activation of inflammation during fulminant RNA virus infection. Antiviral Research 83: 10-20.
2. Reeves JD, Piefer AJ (2005) Emerging drug targets for antiretroviral therapy. Drugs 65: 1747-1766.
3. Greco A, Callé A, Morfin F, Thouvenot D, Cayre M, et al. (2005) S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target. The FASEB Journal: 19: 1128-1130.
4. Ludwig S (2009) Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. The Journal of Antimicrobial Chemotherapy 64: 1-4.
5. Lamb RA, Krug RM (2001) Orthomyxoviridae: the viruses and their replication. In: Howley DMKaPM, ed. Fields's Virology. Philadelphia: Lippincott Williams and Wilkins. pp 1487-1531.
6. Michaelis M, Doerr H, Cinatl J (2009) An Influenza A H1N1 Virus Revival - Pandemic H1N1/09 Virus. Infection 37: 381-389.
7. WHO (2009) WHO Influenza (Seasonal). Available: http://www.who.int/ mediacentre/factsheets/fs211/en. Accessed: 2009 December 21.
8. Hayden FG (2006) Antivirals for influenza: historical perspectives and lessons learned. Antiviral Research 71: 372-378.
9. Kash JC, Basler CF, García-Sastre A, Carter V, Billharz R, et al. (2004) Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. Journal of Virology 78: 9499-9511.
10. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
11. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, et al. (2008) Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. Journal of Virology 82: 11308-11317.
12. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proceedings of the National Academy of Sciences of the United States of America 106: 3455-3460.
13. Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nature Reviews Cancer 7: 54-60.
14. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935.
15. Moules V, Ferraris O, Terrier O, Giudice E, Yver M, et al. (2010) In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: Toward a new mechanism of viral resistance? Virology 404: 215-224.
16. Puthier D, Joly F, Irla M, Saade M, Victorero G, et al. (2004) A general survey of thymocyte differentiation by transcriptional analysis of knockout mouse models. Journal of Immunology 173: 6109-6118.
17. Lopez F, Rougemont J, Loriod B, Bourgeois A, Loï L, et al. (2004) Feature extraction and signal processing for nylon DNA microarrays. BMC Genomics 5: 38.
18. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: R80.
19. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98: 5116-5121.
20. Schwender H, Ickstadt K (2008) Empirical Bayes analysis of single nucleotide polymorphisms. BMC Bioinformatics 9: 144.
21. Benjamini Y, Hochberg, Y: (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
23. Fautz R, Husein B, Hechenberger C (1991) Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutation Research 253: 173-179.
24. Smee DF, Morrison AC, Barnard DL, Sidwell RW (2002) Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. Journal of Virological Methods 106: 71-79.
25. Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters 160: 171-177.
26. Eichelberger MC, Hassantoufighi A, Wu M, Li M (2008) Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Virology Journal 5: 109.
27. Jonges M, Liu WM, van der Vries E, Jacobi R, Pronk I, et al. (2010) Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling. J Clin Microbiol 48: 928-940.
28. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. The American Journal of Physiology 235: E97-E102.
29. Ritz C, Streibig JC (2005) Bioassay Analysis using R. J Statist Software 12.
30. Guo Y, Rumschlag-Booms E, Wang J, Xiao H, Yu J, et al. (2009) Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virology Journal 6: 39.
31. Kanai Y, Chittaganpitch M, Nakamura I, Li G-M, Bai G-R, et al. (2010) Distinct propagation efficiencies of H5N1 influenza virus Thai isolates in newly established murine respiratory region-derived cell clones. Virus Research In Press.
32. Li IWS, Chan KH, To KWK, Wong SSY, Ho PL, et al. (2009) Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. Journal of Clinical Virology 46: 325-330.
33. Lee D, Mok C, Law A, Peiris M, Lau A (2010) Differential replication of avian influenza H9N2 viruses in human alveolar epithelial A549 cells. Virology Journal 7: 71.
34. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, et al. (2009) Avian Influenza Virus Glycoproteins Restrict Virus Replication and Spread through Human Airway Epithelium at Temperatures of the Proximal Airways. PLoS Pathog 5: e1000424.
35. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, et al. (1989) The major human rhinovirus receptor is ICAM-1. Cell 56: 839-847.
36. Ning S, Hahn AM, Huye LE, Pagano JS (2003) Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. Journal of Virology 77: 9359-9368.
37. Shapira SD, Gat-Viks I, Shum BOV, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267.
38. Baskin CR, García-Sastre A, Tumpey TM, Bielefeldt-Ohmann H, Carter VS, et al. (2004) Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). Journal of Virology 78: 10420-10432.
39. Tong HH, Long JP, Li D, DeMaria TF (2004) Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microbial Pathogenesis 37: 193-204.
40. Schmolke M, Viemann D, Roth J, Ludwig S (2009) Essential impact of NFkappaB signaling on the H5N1 influenza A virus-induced transcriptome. Journal of Immunology 183: 5180-5189.
41. Baas T, Baskin CR, Diamond DL, García-Sastre A, Bielefeldt-Ohmann H, et al. (2006) Integrated molecular signature of disease: analysis of influenza virusinfected macaques through functional genomics and proteomics. Journal of Virology 80: 10813-10828.
42. Smee DF, Huffman JH, Morrison AC, Barnard DL, Sidwell RW (2001) Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrobial Agents and Chemotherapy 45: 743-748.
43. Hoffmann HH, Palese P, Shaw ML (2008) Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Research 80: 124-134.
44. Klein M, Brewer JH (1948) The inactivation of influenza virus by mercurials and the reactivation of sodium thioglycolate and BAL. Journal of Immunology 59: 135-140.
45. Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF (2005) In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Research 68: 10-17.
46. Ludwig S, Planz O, Pleschka S, Wolff T (2003) Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends in Molecular Medicine 9: 46-52.
47. Naffakh N, Tomoiu A, Rameix-Welti M-A, van der Werf S (2008) Host Restriction of Avian Influenza Viruses at the Level of the Ribonucleoproteins. Annual Review of Microbiology 62: 403-424.
48. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJD, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Medicine 12: 1203-1207.
49. Chan RWY, Yuen KM, Yu WCL, Ho CCC, Nicholls JM, et al. (2010) Influenza H5N1 and H1N1 Virus Replication and Innate Immune Responses in Bronchial Epithelial Cells Are Influenced by the State of Differentiation. PLoS One 5(1): e8713.
50. Marjuki H, Yen H-L, Franks J, Webster RG, Pleschka S, et al. (2007) Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virology Journal 4: 134.
51. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, et al. (2001) Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. Journal of Virology 75: 4321-4331.
52. Katze MG, Krug RM (1984) Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Molecular and Cellular Biology 4: 2198-2206.
53. Hale BG, Randall RE, Ortín J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. The Journal of General Virology 89: 2359-2376.
54. Bjornson AB, Mellencamp MA, Schiff GM (1991) Complement is activated in the upper respiratory tract during influenza virus infection. The American Review of Respiratory Disease 143: 1062-1066.
55. Zhang H, Su YA, Hu P, Yang J, Zheng B, et al. (2006) Signature patterns revealed by microarray analyses of mice infected with influenza virus A and Streptococcus pneumoniae. Microbes and Infection 8: 2172-2185.
56. El Kasmi KC, Smith AM, Williams L, Neale G, Panopolous A, et al. (2007) Cutting Edge: A Transcriptional Repressor and Corepressor Induced by the STAT3-Regulated Anti-Inflammatory Signaling Pathway. J Immunol 179: 7215-7219.
57. Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (2009) beta- Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) Food and Chemical Toxicology 48: 839-345.
58. Im J-H, Jin Y-R, Lee J-J, Yu J-Y, Han X-H, et al. (2009) Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation. Vascular Pharmacology 50: 147-152.
59. Abe A, Yamada H (2009) Harmol induces apoptosis by caspase-8 activation independently of Fas/Fas ligand interaction in human lung carcinoma H596 cells. Anti-Cancer Drugs 20: 373-381.
60. Root CN, Wills EG, McNair LL, Whittaker GR (2000) Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. The Journal of General Virology 81: 2697-2705.
61. Kurokawa M, Koyama AH, Yasuoka S, Adachi A (1999) Influenza virus overcomes apoptosis by rapid multiplication. International Journal of Molecular Medicine 3: 527-530.
62. Chan-Tack KM, Murray JS, Birnkrant DB (2009) Use of ribavirin to treat influenza. The New England Journal of Medicine 361: 1713-1714.
63. Leyssen P, De Clercq E, Neyts J (2008) Molecular strategies to inhibit the replication of RNA viruses. Antiviral Research 78: 9-25.
64. Zhang Y, Jamaluddin M, Wang S, Tian B, Garofalo RP, et al. (2003) Ribavirin Treatment Up-Regulates Antiviral Gene Expression via the Interferon- Stimulated Response Element in Respiratory Syncytial Virus-Infected Epithelial Cells. Journal of Virology 77: 5933-5947.
65. Feld JJ, Nanda S, Huang Y, Chen W, Cam M, et al. (2007) Hepatic Gene Expression During Treatment with Peginterferon and Ribavirin: Identifying Molecular Pathways for Treatment Response. Hepatology 46: 1548-1563.
66. Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, et al. (2010) Ribavirin improves early responses to peginterferon through enhanced interferon signaling. Gastroenterology 139: 154-162.
67. Cruz DN (2000) Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension. Expert Opinion on Pharmacotherapy 1: 835-840.
68. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, Ross SA, Papay RS, et al. (2003) Genetic Profiling of a1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130. Molecular Pharmacology 63: 1104-1116.
69. Gonzalez-Cabrera PJ, Shi T, Yun J, McCune DF, Rorabaugh BR, et al. (2004) Differential Regulation of the Cell Cycle by {alpha}1-Adrenergic Receptor Subtypes. Endocrinology 145: 5157-5167.
70. Shi T, Duan Z-H, Papay R, Pluskota E, Gaivin RJ, et al. (2006) Novel a1- Adrenergic Receptor Signaling Pathways: Secreted Factors and Interactions with the Extracellular Matrix. Molecular Pharmacology 70: 129-142.
71. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
72. Karlas A, Machuy N, Shin Y, Pleissner K-P, Artarini A, et al. (2010) Genomewide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463: 818-822.
73. König R, Stertz S, Zhou Y, Inoue A, Heinrich Hoffmann H, et al. (2010) Human host factors required for influenza virus replication Nature 463: 813-817.